BR112015014917A2 - uso de compostos de complexo de ferro(iii)-2-oxo-butanodiamida ou sais farmaceuticamente aceitáveis dos mesmos; medicamento; e uso de composições - Google Patents

uso de compostos de complexo de ferro(iii)-2-oxo-butanodiamida ou sais farmaceuticamente aceitáveis dos mesmos; medicamento; e uso de composições

Info

Publication number
BR112015014917A2
BR112015014917A2 BR112015014917A BR112015014917A BR112015014917A2 BR 112015014917 A2 BR112015014917 A2 BR 112015014917A2 BR 112015014917 A BR112015014917 A BR 112015014917A BR 112015014917 A BR112015014917 A BR 112015014917A BR 112015014917 A2 BR112015014917 A2 BR 112015014917A2
Authority
BR
Brazil
Prior art keywords
iron
iii
compositions
complex compounds
medicine
Prior art date
Application number
BR112015014917A
Other languages
English (en)
Inventor
Kalogerakis Aris
Canclini Camillo
Sieber Diana
Philipp Erik
Funk Felix
Dürrenberger Franz
Schmitt Jörg
Schwarz Katrin
Burgert Michael
Otto Geisser Peter
Mayer Simona
Reim Stefan
Burckhardt Susanna
Bark Thomas
Buhr Wilm
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of BR112015014917A2 publication Critical patent/BR112015014917A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

resumo uso de compostos de complexo de ferro(iii)-2-oxo- butanodiamida ou sais farmaceuticamente aceitáveis dos mesmos; medicamento; e uso de composições a invenção se refere a compostos de complexo de ferro(iii) e composições farmacêuticas compreendendo os mesmos para o uso como medicamentos, em particular, para o tratamento e/ou profilaxia de sintomas de deficiência de ferro e anemias por deficiência de ferro.
BR112015014917A 2012-12-21 2013-12-19 uso de compostos de complexo de ferro(iii)-2-oxo-butanodiamida ou sais farmaceuticamente aceitáveis dos mesmos; medicamento; e uso de composições BR112015014917A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12199075 2012-12-21
PCT/EP2013/077383 WO2014096193A1 (de) 2012-12-21 2013-12-19 Fe(iii)-komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien

Publications (1)

Publication Number Publication Date
BR112015014917A2 true BR112015014917A2 (pt) 2017-07-11

Family

ID=47500992

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015014917A BR112015014917A2 (pt) 2012-12-21 2013-12-19 uso de compostos de complexo de ferro(iii)-2-oxo-butanodiamida ou sais farmaceuticamente aceitáveis dos mesmos; medicamento; e uso de composições

Country Status (14)

Country Link
US (1) US9452152B2 (pt)
EP (1) EP2934508B1 (pt)
JP (1) JP6172691B2 (pt)
KR (1) KR101798605B1 (pt)
CN (1) CN105246473B (pt)
AR (1) AR094237A1 (pt)
AU (1) AU2013366649B2 (pt)
BR (1) BR112015014917A2 (pt)
CA (1) CA2891572A1 (pt)
ES (1) ES2658818T3 (pt)
MX (1) MX2015007974A (pt)
RU (1) RU2641030C2 (pt)
TW (1) TW201429470A (pt)
WO (1) WO2014096193A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8976994B2 (en) 2012-06-20 2015-03-10 Apple Inc. Earphone having an acoustic tuning mechanism
RU2759044C1 (ru) * 2020-09-23 2021-11-09 Федеральное государственное бюджетное учреждение "Российский научно-исследовательский институт гематологии и трансфузиологии Федерального медико-биологического агентства" (ФГБУ РосНИИГТ ФМБА России) Способ коррекции анемии в предоперационном периоде у больных раком желудка

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US474670A (en) 1892-05-10 Automatic fire-alarm
GB2128998B (en) 1982-10-22 1986-07-16 Nat Res Dev Pharmaceutical compositions of iron complexes of 3 hydroxy-4-pyrone
GB8325496D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US4788281A (en) 1984-01-04 1988-11-29 Tosoni Anthony L Dextran hexonic acid derivative, ferric hydroxide complex and method manufacture thereof
GB8410289D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
IT1222654B (it) 1987-09-14 1990-09-12 Schering Ag Complesso micellare di ferro-citrato
JPH0283400A (ja) 1988-09-21 1990-03-23 Snow Brand Milk Prod Co Ltd 鉄カゼインの製造方法
ES2044777B1 (es) 1992-03-03 1994-08-01 Dabeer Sa Procedimiento de obtencion de un quelato de hierro de gran solubilidad.
US20030236224A1 (en) 1997-12-09 2003-12-25 Hedlund Bo E. Modified polysaccharides exhibiting altered biological recognition
IT1297022B1 (it) 1997-12-24 1999-08-03 Chemi Spa Complesso di ferro-succinilcaseina, processo per la sua preparazione e composizioni farmaceutiche che lo contengono
DE10253843B3 (de) 2002-11-14 2004-05-06 Bizerba Gmbh & Co. Kg Etikettiervorrichtung für bewegte Gegenstände und Verfahren zur Etikettierung von bewegten Gegenständen
SE0400235D0 (sv) * 2004-02-06 2004-02-06 Active Biotech Ab New composition containing quinoline compounds
EP2015647A2 (en) * 2004-10-08 2009-01-21 Unilever N.V. Iron complex for use in the treatment and/or prevention of nutritional disorders
US20090035385A1 (en) 2004-12-22 2009-02-05 Drugtech Corporation Compositions including iron
CN100443485C (zh) 2005-04-08 2008-12-17 吴华君 叶绿酸合铁钠盐衍生物、制备方法及用途
WO2007062546A1 (fr) 2005-11-30 2007-06-07 Chongqing Pharmaceutical Research Institute Co., Ltd. Complexes fer-saccharide faciles a reconstituer et leur procede de fabrication
EP1947120A1 (de) * 2007-01-19 2008-07-23 Vifor (International) Ag Eisen-Kohlenhydrat-Komplex-Verbindungen
FR2916592B1 (fr) 2007-05-25 2017-04-14 Groupe Des Ecoles De Telecommunications(Get)-Ecole Nat Superieure Des Telecommunications(Enst) Procede de securisation d'echange d'information,dispositif, et produit programme d'ordinateur correspondant
CN101481404B (zh) 2008-12-17 2011-10-05 中国农业大学 一种酶解乳蛋白亚铁络合物微胶囊补铁剂及其制备方法
CN102892415B (zh) 2010-03-23 2016-10-19 维福（国际）股份公司 用于治疗和预防铁缺乏症状及缺铁性贫血的Fe(Ⅲ)配合物化合物
MX358194B (es) 2011-03-29 2018-07-16 Vifor Int Ag Compuestos de complejos de fe(iii) para el tratamiento y profilaxis de sintomas de deficiencia de hierro y anemias por deficiencia de hierro.
US20140248342A1 (en) 2011-05-31 2014-09-04 Vifor (International) Ag Fe(III) 2,4-Dioxo-1-Carbonyl Complexes For Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anaemias

Also Published As

Publication number Publication date
JP2016508975A (ja) 2016-03-24
TW201429470A (zh) 2014-08-01
AU2013366649A1 (en) 2015-06-04
CN105246473A (zh) 2016-01-13
RU2015129842A (ru) 2017-01-25
EP2934508A1 (de) 2015-10-28
US9452152B2 (en) 2016-09-27
AR094237A1 (es) 2015-07-22
ES2658818T3 (es) 2018-03-12
KR101798605B1 (ko) 2017-11-16
MX2015007974A (es) 2016-03-09
EP2934508B1 (de) 2017-12-06
RU2641030C2 (ru) 2018-01-15
AU2013366649B2 (en) 2018-02-01
CA2891572A1 (en) 2014-06-26
WO2014096193A1 (de) 2014-06-26
US20150313864A1 (en) 2015-11-05
CN105246473B (zh) 2018-07-13
JP6172691B2 (ja) 2017-08-02
KR20150099755A (ko) 2015-09-01

Similar Documents

Publication Publication Date Title
BR112015011036A2 (pt) derivados de 2-amino-quinazolina substituídos heterocíclicos para o tratamento de infecções virais
BR112012023780A2 (pt) compostos complexos de ferro (iii) - b - cetoamida ou sais farmaceuticamente toleráveis desses, processo para a produção dos compostos complexos de ferro (iii), uso de compostos complexos de ferro (iii), fármaco contendo compostos complexos de ferro (iii) e composição contendo compostos complexos de ferro (iii)
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
TN2015000278A1 (en) Autotaxin inhibitors
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
BR112015000704A2 (pt) imidazotriazinacarbonitrilas úteis como inibidores de quinase
UA113651C2 (xx) Макроциклічні пурини для лікування вірусних інфекцій
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
BR112013026397A2 (pt) Compostos cromenona como inibidores de pi 3-cinase para o tratamento de câncer
EA202090860A1 (ru) Аналоги тиадиазола и способы лечения состояний, связанных с дефицитом smn
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
EA201590862A1 (ru) Фармацевтические композиции
UA117154C2 (uk) Антагоністи s1p3
BR112014009580A2 (pt) composição farmacêutica de omeprazol
BR112013024722A2 (pt) compostos de complexo de pirimidina-2-ol-1-óxido de ferro(iii) ou seus sais farmaceuticamente aceitáveis, medicamento e composição
BR112015014917A2 (pt) uso de compostos de complexo de ferro(iii)-2-oxo-butanodiamida ou sais farmaceuticamente aceitáveis dos mesmos; medicamento; e uso de composições
BR112015024571A2 (pt) compostos de complexo de ferro(iii), medicamento, e, composição
EA201500366A1 (ru) Применение 1-адамантилетилокси-3-морфолино-2-пропанола или его фармацевтически приемлемых солей в фармацевтических композициях в качестве нейроретинопротектора
TR200907915A2 (tr) Kuru toz formunda farmasötik bileşim.
TN2013000089A1 (en) Triazine-oxadiazoles
UA112586C2 (uk) Похідні бензімідазолпроліну

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06I Technical and formal requirements: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements